Skip to content
Search AI Powered

Latest Stories

Drugmaker Sandoz to pay $265m to settle US pricing case

Drugmaker Sandoz to pay $265m to settle US pricing case

Swiss generic drugmaker Sandoz said on Thursday that it would pay $265 million (£209m) to settle a pricing antitrust case in the US.

Under the agreement, Sandoz is resolving all damages claims without admitting to any wrongdoing in the case brought in the US state of Pennsylvania.


"Under the terms of the agreement, Sandoz US will pay $265 million in exchange for a full release of all claims asserted against it in the direct purchaser class action by the settlement class members," the company said in a statement, adding that the payment would be incorporated into 2023 results.

Sandoz became an independent company in October 2023, following the spinoff from Novartis.

"As a new public company, this settlement underscores the Sandoz commitment to integrity and sound governance, and is an encouraging step toward putting allegations of legacy conduct behind us", it said in its statement.

In a separate case in 2020, Sandoz had agreed to pay $195m to avoid trial in the US on charges it conspired to fix prices of generic drugs.

(AFP)

More For You

weight-loss websites - your local pharmacist

Many Independents offers a weight loss management programme that doesn’t have a faceless dealer

Pic credit: iStock

Avoid rogue weight-loss websites - your local pharmacist is the safest way to lose those pounds

By Jeremy Meader

More than a quarter of adults in England are considered clinically obese, which puts tremendous strain on healthcare services.

Keep ReadingShow less
Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
Pharmacies warn against buying unlicensed hay fever treatment Kenalog® online

Kenalog® can cause serious mental health problems.

gettyimages

Don’t buy unlicensed hay fever drug Kenalog® online, pharmacies warn

Patients are being urged to avoid buying unlicensed medications such as Kenalog® online to treat hay fever symptoms this spring, as pharmacists report a sharp rise in public interest in the drug.

The National Pharmacy Association (NPA), which represents over 6000 independent community pharmacies, has warned patients that buying medication from unregulated sellers, such as beauty salons and from social media sites, could serious health risks.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less